ICRA maintains stable outlook for Indian pharma companies
Domestic pharma cos expected to grow at a CAGR of around 10-12 per cent between FY2019-2022
ICRA has maintained a stable…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ICRA
Indian pharma industry to grow at 11-13 per cent in FY2020: ICRA
Moderation in pricing pressure for the US market, new launches and market share gains for existing products and consolidation…
Pharma sector growth likely to remain strong: ICRA
The sector has witnessed steady demand across therapy segments, regular new launches and price hikes taken by companies in line…
Generic opportunities outweigh challenges emanating across emerging markets: ICRA
Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India…